Atidarsagene autotemcel, marketed under the model name Libmeldy among Many others, is usually a gene therapy cure for metachromatic leukodystrophy formulated by Orchard Therapeutics. Compared with common medicines that need elimination from the body, Lenmeldy doesn't need to be removed. Biodistribution studies have revealed that Lenmeldy is dispersed to hematopoietic https://charlesf802ijk7.wikiparticularization.com/user